Marijuana products present unique testing hurdles
Cannabis testing and quality control is no simple feat.
Consider the plant itself: Cannabis contains a super sticky, resin lipid that is harder to work with than coffee, tobacco and most other natural products, said David Vaillencourt, CEO of the GMP Collective consulting firm in Colorado.
Standards organizations look to create uniform cannabis testing methods
While cannabis has enjoyed greater social acceptance in recent years, quality control will be critical to sustaining that growth and winning over the institutions that have yet to embrace a regulated marijuana industry.
Which branch of the US government will reform marijuana law?
Something’s going to give, and soon. That’s the forecast from many cannabis industry observers for federal marijuana reform. The real question is how.
Cannabis lobbyists believe incremental steps are the most likely path to federal reform
While not impossible, comprehensive marijuana reform that includes federal legalization of the plant in the form of one bill would be a politically heavy lift in today’s divisive Congress.
So it’s important to focus on the most politically palatable and plausible ways to make progress, said Saphira Galoob, principal and CEO of The Liaison Group, a cannabis lobbying firm in Washington DC.
Pros and cons of moving marijuana from Schedule 1 on the list of controlled substances
The absurdity of federal marijuana policy in the United States is perhaps best symbolized by the placement of cannabis on Schedule 1 of the Controlled Substances Act, according to industry observers.
A court case challenging the legality of marijuana prohibition could spur reform
Many cannabis industry observers have pinned their hopes for federal marijuana legalization on an act of Congress or even an executive order from the president.
But there’s another option: legal challenges through the U.S. court system.
